Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Photosensitization Potential of Finasteride Cutaneous Solution (P-3074)
NCT02791243Phase 1Completed
- Sponsor
- Polichem
- Start
- May 2016
- Primary completion
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial of finasteride in androgenetic alopecia (AGA) (3 arms), sponsored by Polichem. Primary endpoint: Potential for induction of photosensitization at Day 42. Started May 2016; status: completed.
02
Drugs
finasteride
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT02791243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02791243.